Long-course oxaliplatin-based preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study.
about
SEOM Clinical Guideline of localized rectal cancer (2016).On a prolonged interval between rectal cancer (chemo)radiotherapy and surgery.Controversies in the multimodality management of locally advanced rectal cancer.Neoadjuvant Treatment for Locally Advanced Rectal Cancer: New Concepts in Clinical Trial Design.Total neoadjuvant therapy for rectal cancer: An emerging option.Neoadjuvant long-course chemoradiation remains strongly favored over short-course radiotherapy by radiation oncologists in the United States.What treatments should be skipped or intensified in localized rectal cancer?Current issues of preoperative radio(chemo)therapy and its future evolution in locally advanced rectal cancer.[Optimal fractionation regimen, and time between radiotherapy and operation in rectal cancer : The multicenter, randomized Stockholm III trial].Contemporary management of locally advanced rectal cancer: Resolving issues, controversies and shifting paradigms.Palliative radiotherapy and chemotherapy instead of surgery in symptomatic rectal cancer with synchronous unresectable metastases: long-term results of a phase II study.RE: Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer.Radiation Oncology in the 21st Century: Prospective Randomized Trials That Changed Practice… or Didn't!Advances for achieving a pathological complete response for rectal cancer after neoadjuvant therapy.Trends and disparities in the utilization of hypofractionated neoadjuvant radiation therapy for rectal cancer in the United StatesEastern Canadian Colorectal Cancer Consensus Conference 2017The potential predictive value of tumor budding for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer
P2860
Q37475229-599C1CDB-56F6-48DC-BFF0-9BD7FEA7FE70Q37715201-3CE51D1D-BD80-4507-86F3-6BE28D19F3CAQ38691264-B0BAF42B-6BCA-4791-94D8-6C15D52534B3Q39172475-A27BE1BE-74A8-4B4B-9082-9FBE78C1FB79Q39179402-E8518A08-65C9-410D-B237-CA88C5CA31A7Q40421115-9442D04B-1A41-4A0E-B74B-2E97A368A039Q47741303-448C4384-A342-4A12-886E-162771E36DF7Q47847007-393465A1-F970-43EE-AB60-9E47D04CF8ACQ50534444-830C29BD-F350-44E5-8434-944ACC5754D5Q52653160-9643075B-577B-4B21-9EAC-09693BE0B2AFQ53102275-35D3DE51-69A8-475B-8924-3B10B2F2B02FQ54376650-CBEE177A-9B7A-4436-8333-D8B39DA4E0BEQ55038620-42098BFB-32B7-4E94-80DB-7B0736B2F149Q55526826-4AD0AB05-DB36-4B4F-A0C5-2BE9612A762DQ57172701-B35F4938-36D9-40DF-A107-2490416323D3Q58783221-29117D9B-D5A1-4352-84A0-9DD74A6EAD66Q58803968-D0EC30FF-5861-46FA-A2E3-54C53A29F459
P2860
Long-course oxaliplatin-based preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Long-course oxaliplatin-based ...... a randomized phase III study.
@en
Long-course oxaliplatin-based ...... a randomized phase III study.
@nl
type
label
Long-course oxaliplatin-based ...... a randomized phase III study.
@en
Long-course oxaliplatin-based ...... a randomized phase III study.
@nl
prefLabel
Long-course oxaliplatin-based ...... a randomized phase III study.
@en
Long-course oxaliplatin-based ...... a randomized phase III study.
@nl
P2093
P2860
P50
P356
P1433
P1476
Long-course oxaliplatin-based ...... f a randomized phase III study
@en
P2093
A Maciejczyk
A Radkowski
A Rutkowski
B Czeremszyńska
B Kapturkiewicz
P2860
P304
P356
10.1093/ANNONC/MDW062
P50
P577
2016-02-15T00:00:00Z